arBtrage CAPITALIZING MARKETS checking… Sign in

Kura Oncology, Inc.

KURA Health Care Biotechnology: Pharmaceutical Preparations
$8.74
▼ -0.3% Today
as of Jun 7, 07:19 ET
Last 30 days -1.02% Apr 28 → Jun 05
$8.45 $9.20 $9.95 $10.71 $11.46 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$8.76
High
$9.21
Low
$8.55
Volume
$3M
Avg Vol
$2M
Mkt Cap
$885M
P/E (TTM)
Beta
52w High
$12.49
52w Low
$5.45
Div Yield
Shares Out
$89M

Overview

52-week range
$5.45
$12
47% of range
Avg surprise (last 2)
-11.9%
Avg reaction (last 2)
+0.4%
50% positive
Latest IV / EM
87%
EM ±12.0% · $9 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.88$-0.79$-0.69$-0.59$-0.50 Actual $-0.53Actual $-0.50Actual $-0.59Actual $-0.59Actual $-0.63Actual $-0.66Est $-0.51Actual $-0.75Actual $-0.85Actual $-0.83Est $-0.88 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-74M$-50M$-26M$-2M$22M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.83 $-0.88 +5.7% -25.8% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.85 financials
Mon Jun 30, 2025Jun 2025 $-0.75 financials
Thu May 1, 2025Mar/2025 $-0.66 $-0.51 -29.4% -1.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.63 financials
Sun Jun 30, 2024Jun 2024 $-0.59 financials
Sun Mar 31, 2024Mar 2024 $-0.59 financials
Sat Sep 30, 2023Sep 2023 $-0.50 financials
Fri Jun 30, 2023Jun 2023 $-0.53 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$18M$21M$15M$14M
Cost of revenue$262,000
Gross profit
Operating income$-79M$-80M$-73M$-65M$-60M$-56M
Net income$-73M$-74M$-66M$-57M$-54M$-51M
EPS (diluted)$-0.83$-0.85$-0.75$-0.66$-0.63$-0.59

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$39M$149M$95M$82M$51M$224M$49M$45M
Inventory$843,000$413,000
Total current assets$624M$709M$621M$660M$724M$745M$463M$500M
Total assets$653M$738M$649M$682M$744M$760M$479M$515M
Long-term debt$10M$10M$5M$7M$8M$7M$8M$9M
Total liabilities$545M$564M$407M$377M$379M$347M$55M$49M
Total equity$108M$174M$243M$305M$364M$414M$424M$466M

Implied volatility — last 90 days

81%84%86%89%91% Jun 07 — IV 87% · EM ±12.0%

Sector peers